Retatrutide is investigational with no FDA-approved dosing protocol, so any split approach should be discussed with a supervising healthcare provider first
Join the club today for exclusive access to in-depth stories, tips and reviews, as well as access to a community of riders, just like you!
Rectal bleeding or the passage of black, tarry stools should never be ignored, as these may signal underlying pathology unrelated to GLP-1 medication
Am J Kidney Dis 2020;76:4546.PubMed 56
At target doses of retatrutide 8-12 mg weekly and cagrilintide 2.0-2.4 mg weekly, monthly costs typically range from moderate to significant depending on the supplier
(9) A rodent model study (9) was conducted, inducing post-operative ileus (POI), wherein half of the subjects were exposed to Ipamorelin while the remaining served as the control group